Unichem Laboratories Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift

Price Momentum and Recent Market Performance

Unichem Laboratories Ltd’s stock price closed at ₹344.00 on 16 Apr 2026, marking a 2.05% increase from the previous close of ₹337.10. The intraday range saw a low of ₹339.50 and a high of ₹353.85, indicating some volatility but a positive bias in trading sentiment. However, the stock remains significantly below its 52-week high of ₹727.95, highlighting a prolonged downtrend over the past year.

When compared with the broader market, Unichem’s returns have been underwhelming. Over the past week, the stock outperformed the Sensex with a 4.29% gain versus the benchmark’s 0.71%. Similarly, the one-month return of 6.77% surpassed the Sensex’s 4.76%. Yet, year-to-date (YTD) figures reveal a stark contrast, with Unichem down 22.06% against the Sensex’s modest decline of 8.34%. Over the last year, the stock has plummeted 43.72%, while the Sensex gained 1.79%. Longer-term returns also lag, with a three-year return of -6.84% compared to the Sensex’s 29.26%, and a five-year return of 10.40% versus the Sensex’s 60.05%. Even the ten-year return of 51.51% falls short of the Sensex’s 204.80%.

Technical Trend Shift: From Bearish to Mildly Bearish

The technical trend for Unichem Laboratories has shifted from a strongly bearish stance to a mildly bearish one, signalling a tentative improvement in market sentiment. This change suggests that while the downtrend is not fully reversed, the intensity of selling pressure has eased somewhat. Investors should note that this shift does not yet indicate a definitive bullish reversal but rather a potential consolidation phase.

On the daily chart, moving averages remain mildly bearish, reflecting that short-term price averages continue to lag behind longer-term trends. This is consistent with the stock’s failure to break above key resistance levels in recent sessions.

MACD and Momentum Indicators

The Moving Average Convergence Divergence (MACD) indicator presents a nuanced picture. On the weekly timeframe, the MACD is mildly bullish, suggesting some upward momentum building in the medium term. This is a positive sign for investors looking for a potential recovery in the stock price. However, the monthly MACD remains bearish, indicating that the longer-term trend is still negative and caution is warranted.

The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in neutral zones. This implies that the stock is neither overbought nor oversold, leaving room for either upward or downward movement depending on market catalysts.

Bollinger Bands and Volatility Assessment

Bollinger Bands on weekly and monthly charts are mildly bearish, reflecting that price volatility remains skewed towards the downside. The bands suggest that the stock price is trading near the lower range of its recent volatility spectrum, which could imply limited downside room but also a lack of strong buying interest at current levels.

Other Technical Indicators: KST, Dow Theory, and OBV

The Know Sure Thing (KST) indicator is bearish on both weekly and monthly timeframes, reinforcing the view that momentum remains subdued. Dow Theory assessments are mixed, with a mildly bullish weekly outlook contrasting with a mildly bearish monthly perspective. This divergence highlights the ongoing uncertainty in the stock’s trend direction.

On a more encouraging note, the On-Balance Volume (OBV) indicator is bullish on both weekly and monthly charts. This suggests that volume trends are supportive of price gains, indicating accumulation by investors despite the broader negative technical backdrop.

Mojo Score and Grade Update

Unichem Laboratories currently holds a Mojo Score of 37.0, categorised as a Sell grade. This represents an upgrade from a previous Strong Sell rating as of 16 Feb 2026. The upgrade reflects the recent technical improvements but also underscores that the stock remains a cautious proposition for investors. The company is classified as a small-cap within the Pharmaceuticals & Biotechnology sector, which typically entails higher volatility and risk.

Investment Outlook and Comparative Analysis

While Unichem Laboratories has shown some signs of stabilisation in its technical parameters, the overall picture remains mixed. The mild bullish signals on weekly MACD and OBV are tempered by bearish monthly momentum indicators and moving averages. The stock’s significant underperformance relative to the Sensex over the past year and longer periods further emphasises the challenges it faces.

Investors should weigh these technical signals alongside fundamental factors and sector dynamics before making allocation decisions. The pharmaceutical industry continues to be competitive and subject to regulatory and innovation risks, which may impact Unichem’s recovery trajectory.

Conclusion: Cautious Optimism Amid Lingering Risks

Unichem Laboratories Ltd’s recent technical parameter changes indicate a tentative shift towards stabilisation, with some momentum indicators improving from deeply bearish levels. However, the persistence of bearish signals on monthly charts and the stock’s prolonged underperformance relative to the Sensex counsel caution. The current Mojo Grade of Sell reflects this balanced view, suggesting that while the stock may offer some near-term trading opportunities, it remains a risky proposition for long-term investors.

Market participants should continue to monitor key technical indicators such as MACD, moving averages, and volume trends closely, alongside fundamental developments within the pharmaceutical sector. Given the mixed signals, a prudent approach would be to await clearer confirmation of trend reversal before committing significant capital to Unichem Laboratories Ltd.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →